Source Intelligence
The Acquisition Expands Source Intelligence's Global Presence, Product Capabilities, and Industry Applicability
SAN DIEGO, CA / ACCESSWIRE / May 23, 2023 / Source Intelligence, an industry-leading software provider of supply chain compliance and ESG management solutions, announces its acquisition of ChainPoint, a software platform for monitoring and securing supply chains.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.ChainPoint specializes in helping companies monitor supply chains by connecting systems and sharing information. The company's secure, cloud-based platform allows users to manage and share product, process, and supplier information from raw material to finished product. The flexibility and scalability of ChainPoint's software allow for applicability in any industry, commodity, and supply chain.
The acquisition of ChainPoint enables Source Intelligence to expand its European presence and allows the two companies to better serve their clients in managing and improving sustainable supply chains while reducing cost and risk.
"Joining forces with Source Intelligence will consolidate our position in international markets and further strengthen the innovation and quality of service our team brings to existing and new clients," says Johan Zandbergen, Founder and CEO of ChainPoint.
Together, ChainPoint and Source Intelligence will deliver a broader, more valuable solution to clients and stakeholders worldwide across a wider range of industries. The partnership also enhances Source Intelligence's robust solutions with traceability capabilities for raw materials such as cocoa beans, cotton, timber, palm oil, and many other commodities.
"The acquisition of ChainPoint allows us to trace more raw materials back to their source and expands our ability to serve clients in other industries, including food, apparel, and retail," comments Glenn Trout, CEO of Source Intelligence. "With a broader range of Supply Chain Compliance and Transparency solutions, we are better positioned to serve our rapidly growing global customer base."
About Source Intelligence: Source Intelligence delivers services and software that streamline the evolving complexities of product compliance and ESG management. The SaaS company, based out of San Diego, California, provides fully scalable solutions for Product Compliance, Responsible Sourcing, Sustainability, and Parts Obsolescence that can be configured for the unique needs of every enterprise. For more information, visit www.sourceintelligence.com.
About ChainPoint: ChainPoint was founded in 2003 by Johan Zandbergen. The company is headquartered in Arnhem, The Netherlands, with additional offices in Germany and France. ChainPoint is a specialized, global vendor of supply chain sustainability software for compliance, transparency, and ESG claim verification. The company facilitates customers worldwide to monitor and manage supply chains and enhance transparency towards customers and other stakeholders. ChainPoint's solutions are used by over 70,000 companies globally and are trusted by world-leading brands such as BCI, Tony's Chocolonely, and Next. For more information, visit www.chainpoint.com.
Contact Information:
Amanda Lindberg
Director of Marketing
amanda.lindberg@sourceintel.com
SOURCE: Source Intelligence
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/756443/Source-Intelligence-Acquires-ChainPoint
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC12.1.2026 13:00:00 CET | Press release
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC. Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market. TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreemen
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access12.1.2026 12:00:00 CET | Press release
SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape Products IKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products. The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products. Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS). COSTA MESA, CA / ACCESS Newswire / January 12, 2026 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Compan
Datavault AI Celebrates Successful Completion of Dream Bowl XIV, Pioneering Blockchain Innovation in Sports Entertainment12.1.2026 12:00:00 CET | Press release
On January 10, 2026, a few dozen of NFL Alumni Greats (click here for a list of participating athletes) live-autographed 100 Footballs (click here to view the autographed NFL Alumni Footballs) and 500 Jerseys (click here to view the autographed NFL Alumni Jerseys); Starting on February 1, 2026, these special, one-time, live-autographed memorabilia items are to be given away by lottery to eligible holders of Dream Bowl Meme Coin I tokens and, following their distribution date (currently set for February 21, 2026), Dream Bowl Meme Coin II tokens and will be tradable on the upcoming International NIL Exchange; $25,000 E-Sports Scholarships Raised by Sponsors were Given to Dream Bowl Madden and Team E-Sports Champions; and 70 Student Star Athletes Showcased their Talent to USFL, NFL and European League Scouts (click here to view the Special Dream Bowl XIV Participants' Jerseys). PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T
Datavault AI Expands IBM Collaboration to Deploy Enterprise-Grade AI at the Edge with Available Infrastructure's SanQtum AI Platform8.1.2026 13:00:00 CET | Press release
Datavault AI will activate a secured multi-city edge AI network for real-time data tokenization, security, and monetization across New York and Philadelphia NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in instant data monetization & enterprise digital twins, announced it will deliver enterprise-grade AI performance at the edge in New York and Philadelphia through an expanded collaboration with IBM using the SanQtum AI platform. Operated by Available Infrastructure, SanQtum AI is a fleet of synchronized micro edge data centers running IBM's watsonx portfolio of AI products on a zero-trust network. The combined deployment is designed to enable cybersecure data storage and compute, real-time data scoring, tokenization, and ultra-low-latency, across two of the most data-dense metro regions in the United States. By running Datavault AI's Information Data Exchange and DataScore agents - built with watsonx - within SanQtum AI's zero-trust edge e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom